Cargando…
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression
Comprehensive genomic studies have delineated key driver mutations linked to disease progression for most cancers. However, corresponding transcriptional changes remain largely elusive because of the bias associated with cross-study analysis. Here, we overcome these hurdles and generate a comprehens...
Autores principales: | Bolis, Marco, Bossi, Daniela, Vallerga, Arianna, Ceserani, Valentina, Cavalli, Manuela, Impellizzieri, Daniela, Di Rito, Laura, Zoni, Eugenio, Mosole, Simone, Elia, Angela Rita, Rinaldi, Andrea, Pereira Mestre, Ricardo, D’Antonio, Eugenia, Ferrari, Matteo, Stoffel, Flavio, Jermini, Fernando, Gillessen, Silke, Bubendorf, Lukas, Schraml, Peter, Calcinotto, Arianna, Corey, Eva, Moch, Holger, Spahn, Martin, Thalmann, George, Kruithof-de Julio, Marianna, Rubin, Mark A., Theurillat, Jean-Philippe P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640014/ https://www.ncbi.nlm.nih.gov/pubmed/34857732 http://dx.doi.org/10.1038/s41467-021-26840-5 |
Ejemplares similares
-
Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer
por: Bernasocchi, Tiziano, et al.
Publicado: (2021) -
Patient-derived xenografts and organoids model therapy response in prostate cancer
por: Karkampouna, Sofia, et al.
Publicado: (2021) -
Ways to Enhance Lymphocyte Trafficking into Tumors and Fitness of Tumor Infiltrating Lymphocytes
por: Bellone, Matteo, et al.
Publicado: (2013) -
Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification
por: Zoni, Eugenio, et al.
Publicado: (2019) -
Won’t you come on in? How to favor lymphocyte infiltration in tumors
por: Bellone, Matteo, et al.
Publicado: (2012)